As of 2026-07-04, the Relative Valuation of Regenxbio Inc (RGNX) is (203.38) USD. This relative valuation is based on P/E multiples. With the latest stock price at 13.28 USD, the upside of Regenxbio Inc based on Relative Valuation is -1631.5%.
The range of the Relative Valuation is (184.42) - (220.93) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 17.7x - 25.9x | 21.8x |
| Forward P/E multiples | 19.7x - 23.6x | 21.6x |
| Fair Price | (184.42) - (220.93) | (203.38) |
| Upside | -1488.7% - -1763.6% | -1631.5% |
| Date | P/E |
| 2026-07-02 | -1.42 |
| 2026-07-01 | -1.40 |
| 2026-06-30 | -1.28 |
| 2026-06-29 | -1.26 |
| 2026-06-26 | -1.12 |
| 2026-06-25 | -1.09 |
| 2026-06-24 | -1.06 |
| 2026-06-23 | -1.06 |
| 2026-06-22 | -0.97 |
| 2026-06-18 | -0.83 |
| 2026-06-17 | -0.84 |
| 2026-06-16 | -0.74 |
| 2026-06-15 | -0.76 |
| 2026-06-12 | -0.71 |
| 2026-06-11 | -0.67 |
| 2026-06-10 | -0.65 |
| 2026-06-09 | -0.68 |
| 2026-06-08 | -0.65 |
| 2026-06-05 | -0.65 |
| 2026-06-04 | -0.73 |
| 2026-06-03 | -0.71 |
| 2026-06-02 | -0.70 |
| 2026-06-01 | -0.76 |
| 2026-05-29 | -0.75 |
| 2026-05-28 | -0.74 |
| 2026-05-27 | -0.71 |
| 2026-05-26 | -0.67 |
| 2026-05-22 | -0.68 |
| 2026-05-21 | -0.72 |
| 2026-05-20 | -0.64 |
| 2026-05-19 | -0.60 |
| 2026-05-18 | -0.60 |
| 2026-05-15 | -0.61 |
| 2026-05-14 | -0.67 |
| 2026-05-13 | -1.07 |
| 2026-05-12 | -1.09 |
| 2026-05-11 | -1.08 |
| 2026-05-08 | -1.13 |
| 2026-05-07 | -1.11 |
| 2026-05-06 | -1.09 |
| 2026-05-05 | -0.98 |
| 2026-05-04 | -1.00 |
| 2026-05-01 | -0.97 |
| 2026-04-30 | -0.96 |
| 2026-04-29 | -0.90 |
| 2026-04-28 | -0.93 |
| 2026-04-27 | -0.92 |
| 2026-04-24 | -0.94 |
| 2026-04-23 | -0.96 |
| 2026-04-22 | -1.00 |